James Faucette

Morgan Stanley | Technology

James Faucette is an analyst from Morgan Stanley specializing in the Technology sector. Ranked #2047 out of 4702 analysts, they have issued 94 stock ratings with a success rate of 82.02% and an average return of 14.90%.

James Faucette has a well-established track record, with 94 ratings issued in the Technology sector. They have consistently delivered a success rate of 82.02% and an average return of 14.90%, underscoring their expertise and ability to identify winning opportunities for investors.

#2047

Out of 4702

94

Total Ratings

+82.02%

Success Rate

+14.90%

Average Return

Recent Ratings Analysis

AFRM

Jun 25, 2026

Target

$79.00

Current

$79.49

Performance

3.44%

James Faucette rated AFRM as Equal-Weight on Jun 25, 2026, setting a price target of 79. The Hold stance appears justified, as shares hovered around 79.49 with a 3.44% move.

CTSH

Jun 23, 2026

Target

$44.00

Current

$40.03

Performance

-2.25%

On Jun 23, 2026, CTSH was given a Equal-Weight rating by James Faucette, with a target price of 44. Market indecision, reflected in sideways trading near 40.03, supported the cautious call.

GPN

Jun 22, 2026

Target

$65.00

Current

$69.80

Performance

7.24%

GPN received a Equal-Weight rating from James Faucette on Jun 22, 2026, aiming for 65. Investors saw gains of 7.24% that the cautious stance didn’t fully capture.

ACN

Jun 22, 2026

Target

$130.00

Current

$128.98

Performance

3.32%

On Jun 22, 2026, James Faucette published a Equal-Weight outlook on ACN, with a target of 130. Sideways action left the Hold view intact, with no major move since 128.98.

FISV

May 29, 2026

Target

$65.00

Current

$49.45

Performance

-12.57%

James Faucette on May 29, 2026 assigned FISV a Equal-Weight rating, with a price target of 65. The call successfully avoided chasing as shares lost 12.57%.

XYZ

May 29, 2026

Target

$98.00

Current

$77.70

Performance

2.61%

On May 29, 2026, James Faucette reaffirmed XYZ with a Overweight rating, targeting 98. Market indecision has kept the 98 target in a holding pattern.

DAVA

May 22, 2026

Target

$4.00

Current

$2.84

Performance

-14.71%

DAVA was rated Equal-Weight by James Faucette on May 22, 2026, with a price objective of 4. Investors who stayed cautious avoided some of the 14.71% decline.

CRCL

May 19, 2026

Target

$106.00

Current

$73.57

Performance

-33.74%

On May 19, 2026, James Faucette initiated coverage on CRCL with a Equal-Weight rating and target of 106. The rating matched the stock’s inability to hold above 73.57.

EVTC

May 19, 2026

Target

$25.00

Current

$27.37

Performance

12.63%

James Faucette issued a Equal-Weight recommendation for EVTC on May 19, 2026, price target set at 25. A neutral call gave way to stronger-than-expected performance, closing in on 25.

KLAR

May 18, 2026

Target

$18.00

Current

$20.29

Performance

30.48%

On May 18, 2026, KLAR was evaluated by James Faucette, who gave a Equal-Weight rating and target of 18. Investors who stayed in despite the Hold saw upside of 30.48%.

DXC

May 14, 2026

Target

$9.00

Current

$8.82

Performance

7.30%

James Faucette rated DXC as Equal-Weight on May 14, 2026, setting a price target of 9. Despite the Hold call, shares climbed 7.30% to 8.82, revealing unexpected momentum.

GLBE

May 14, 2026

Target

$37.00

Current

$36.41

Performance

30.31%

On May 14, 2026, GLBE was given a Overweight rating by James Faucette, with a target price of 37. The stock rallied 30.31% after the rating, narrowing the gap to the target of 37 and validating the bullish stance.

FLYW

May 06, 2026

Target

$20.00

Current

$17.54

Performance

0.17%

FLYW received a Overweight rating from James Faucette on May 06, 2026, aiming for 20. Price action was muted, as shares hovered around 17.54 despite the bullish outlook.

EPAM

May 05, 2026

Target

$148.00

Current

$80.68

Performance

-26.41%

On May 05, 2026, James Faucette published a Equal-Weight outlook on EPAM, with a target of 148. Weakness in the stock, now at 80.68, supported the conservative rating.

SSNC

Apr 24, 2026

Target

$78.00

Current

$63.66

Performance

—

James Faucette on Apr 24, 2026 assigned SSNC a Equal-Weight rating, with a price target of 78. The Hold stance reflected consolidation, as shares held near 63.66.

NCNO

Apr 01, 2026

Target

$23.00

Current

$15.63

Performance

-5.67%

On Apr 01, 2026, James Faucette reaffirmed NCNO with a Overweight rating, targeting 23. Shares slid 5.67% despite the recommendation, highlighting downside risks.

KD

Mar 24, 2026

Target

$13.00

Current

$11.32

Performance

-8.41%

KD was rated Equal-Weight by James Faucette on Mar 24, 2026, with a price objective of 13. Investors who stayed cautious avoided some of the 8.41% decline.

NRDS

Mar 13, 2026

Target

$14.00

Current

$9.08

Performance

-8.56%

On Mar 13, 2026, James Faucette initiated coverage on NRDS with a Underweight rating and target of 14. Shares gained despite the bearish call, moving higher from 9.08.

RPAY

Mar 11, 2026

Target

$4.00

Current

$3.58

Performance

26.06%

James Faucette issued a Equal-Weight recommendation for RPAY on Mar 11, 2026, price target set at 4. A neutral call gave way to stronger-than-expected performance, closing in on 4.

TASK

Mar 02, 2026

Target

$16.50

Current

$4.73

Performance

-55.25%

On Mar 02, 2026, TASK was evaluated by James Faucette, who gave a Equal-Weight rating and target of 16.5. The Hold call avoided chasing into subsequent weakness of 55.25%.

VRRM

Feb 25, 2026

Target

$24.00

Current

$4.50

Performance

-72.19%

James Faucette rated VRRM as Equal-Weight on Feb 25, 2026, setting a price target of 24. The cautious Hold call aligned with subsequent weakness, as shares slipped 72.19%.

MQ

Feb 25, 2026

Target

$6.00

Current

$4.18

Performance

8.29%

On Feb 25, 2026, MQ was given a Equal-Weight rating by James Faucette, with a target price of 6. The stock rallied from 4.18 to 4.18 after the Hold rating, surprising to the upside.

IIIV

Feb 10, 2026

Target

$28.00

Current

$21.29

Performance

-7.80%

IIIV received a Equal-Weight rating from James Faucette on Feb 10, 2026, aiming for 28. The Hold stance proved prudent, with the market softening by 7.80%.

JKHY

Feb 05, 2026

Target

$183.00

Current

$135.00

Performance

-23.71%

On Feb 05, 2026, James Faucette published a Equal-Weight outlook on JKHY, with a target of 183. Weakness in the stock, now at 135, supported the conservative rating.

CPAY

Feb 05, 2026

Target

$390.00

Current

$332.48

Performance

-0.75%

James Faucette on Feb 05, 2026 assigned CPAY a Overweight rating, with a price target of 390. The recommendation remains pending validation as shares consolidate around 332.48.

GLXY

Feb 04, 2026

Target

$36.00

Current

$29.26

Performance

45.14%

On Feb 04, 2026, James Faucette reaffirmed GLXY with a Overweight rating, targeting 36. The recommendation was supported by strong follow-through as the stock rose from 29.26 to 29.26.

PYPL

Feb 04, 2026

Target

$34.00

Current

$44.29

Performance

7.95%

PYPL was rated Underweight by James Faucette on Feb 04, 2026, with a price objective of 34. Bearish sentiment was justified as the stock retreated to 44.29.

V

Jan 30, 2026

Target

$411.00

Current

$336.23

Performance

4.47%

On Jan 30, 2026, James Faucette initiated coverage on V with a Overweight rating and target of 411. Neutral price movement of 4.47% leaves room for interpretation.

MA

Jan 30, 2026

Target

$678.00

Current

$499.02

Performance

-7.38%

James Faucette issued a Overweight recommendation for MA on Jan 30, 2026, price target set at 678. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

ADP

Jan 29, 2026

Target

$274.00

Current

$223.55

Performance

-9.11%

On Jan 29, 2026, ADP was evaluated by James Faucette, who gave a Equal-Weight rating and target of 274. The Hold call avoided chasing into subsequent weakness of 9.11%.

CWAN

Jan 27, 2026

Target

$24.55

Current

$24.56

Performance

1.78%

James Faucette rated CWAN as Equal-Weight on Jan 27, 2026, setting a price target of 24.55. The Hold stance appears justified, as shares hovered around 24.56 with a 1.78% move.

PAYX

Dec 22, 2025

Target

$133.00

Current

$99.90

Performance

-13.04%

On Dec 22, 2025, PAYX was given a Equal-Weight rating by James Faucette, with a target price of 133. The rating provided protection from downside risk as the stock fell to 99.9.

BR

Nov 05, 2025

Target

$256.00

Current

$137.93

Performance

-36.90%

BR received a Equal-Weight rating from James Faucette on Nov 05, 2025, aiming for 256. The Hold stance proved prudent, with the market softening by 36.90%.

FOUR

Oct 03, 2025

Target

$86.00

Current

$47.61

Performance

-38.06%

On Oct 03, 2025, James Faucette published a Equal-Weight outlook on FOUR, with a target of 86. Weakness in the stock, now at 47.61, supported the conservative rating.

UWMC

Sep 29, 2025

Target

$6.50

Current

$2.18

Performance

-64.95%

James Faucette on Sep 29, 2025 assigned UWMC a Equal-Weight rating, with a price target of 6.5. The call successfully avoided chasing as shares lost 64.95%.

UPST

Aug 06, 2025

Target

$70.00

Current

$33.66

Performance

-49.87%

On Aug 06, 2025, James Faucette reaffirmed UPST with a Equal-Weight rating, targeting 70. The Hold stance reflected market caution that was later justified.

TIXT

Aug 04, 2025

Target

$3.40

Current

$4.31

Performance

15.24%

TIXT was rated Equal-Weight by James Faucette on Aug 04, 2025, with a price objective of 3.4. Despite caution, upside momentum rewarded risk-takers with gains to 4.31.

WU

Jul 29, 2025

Target

$7.00

Current

$7.53

Performance

-6.92%

On Jul 29, 2025, James Faucette initiated coverage on WU with a Underweight rating and target of 7. Shares gained despite the bearish call, moving higher from 7.53.

WEX

Jul 25, 2025

Target

$170.00

Current

$138.01

Performance

-21.42%

James Faucette issued a Equal-Weight recommendation for WEX on Jul 25, 2025, price target set at 170. Market action validated the conservative Hold outlook with shares at 138.01.

CHYM

Jul 07, 2025

Target

$39.00

Current

$20.32

Performance

-35.80%

On Jul 07, 2025, CHYM was evaluated by James Faucette, who gave a Overweight rating and target of 39. Investors saw limited payoff as shares fell short of the 39 target.

AVDX

Feb 27, 2025

Target

$8.00

Current

$10.00

Performance

35.87%

James Faucette rated AVDX as Equal-Weight on Feb 27, 2025, setting a price target of 8. Despite the Hold call, shares climbed 35.87% to 10, revealing unexpected momentum.

FIS

Feb 12, 2025

Target

$86.00

Current

$38.57

Performance

-46.86%

On Feb 12, 2025, FIS was given a Equal-Weight rating by James Faucette, with a target price of 86. The rating provided protection from downside risk as the stock fell to 38.57.

RKT

Dec 19, 2024

Target

$13.00

Current

$15.00

Performance

28.98%

RKT received a Equal-Weight rating from James Faucette on Dec 19, 2024, aiming for 13. Investors saw gains of 28.98% that the cautious stance didn’t fully capture.

SQ

Dec 18, 2024

Target

$65.00

Current

$83.46

Performance

-4.40%

On Dec 18, 2024, James Faucette published a Underweight outlook on SQ, with a target of 65. The rating remains inconclusive as the market consolidates near 83.46.

QTWO

May 02, 2024

Target

$50.00

Current

$47.91

Performance

-19.59%

James Faucette on May 02, 2024 assigned QTWO a Equal-Weight rating, with a price target of 50. The call successfully avoided chasing as shares lost 19.59%.

Frequency Asked Questions

Who is James Faucette?

James Faucette is an analyst from Morgan Stanley specializing in the Technology sector.

What is James Faucette's success rate?

James Faucette currently has a success rate of +82.02%.

How many ratings has James Faucette issued?

James Faucette has issued 94 stock ratings so far.

What is the average return of James Faucette's calls?

Their stock ratings have generated an average return of +14.90%.

What is James Faucette's ranking?

James Faucette is ranked #2047 out of 4702 analysts.

What types of ratings does James Faucette give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow James Faucette?

You can follow James Faucette by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by James Faucette?

Their latest rating was a Hold on AFRM issued on 2026-06-25.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep